Home LiteratureArticle Details
PMID: 1427073 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.

Genes & development ·Vol. 6 ·No. 11 ·1992-11-00 ·Pages 2077-87

Tiley LS, Madore SJ, Malim MH, Cullen BR

Abstract

Among eukaryotic transcription trans-activators, the human immunodeficiency virus type 1 (HIV-1) Tat protein is exceptional in that its target site TAR is an RNA rather than a DNA sequence. Here, we confirm that fusion of Tat to the RNA-binding domain of the HIV-1 Rev protein permits the efficient activation of an HIV-1 long terminal repeat (LTR) promoter in which critical TAR sequences have been replaced by RNA sequences derived from the HIV-1 Rev response element (RRE). An RRE target sequence as small as 13 nucleotides is shown to form an effective in vivo target for Rev binding. More important, a fusion protein consisting of Rev attached to the VP16 transcription activation domain was also observed to efficiently activate the HIV-1 LTR from this nascent RNA target. These data demonstrate that trans-activation of transcription by acidic activation domains does not require a stable interaction with the promoter DNA and suggest that VP16, like Tat, can act on steps subsequent to the formation of the HIV-1 LTR preinitiation complex. The finding that the activation domains of VP16 and Tat are functionally interchangeable raises the possibility that these apparently disparate viral trans-activators may nevertheless act via similar mechanisms.

MeSH Terms
Base Sequence Binding Sites Cell Line Chloramphenicol O-Acetyltransferase/genetics,metabolism Gene Products, rev/isolation & purification,metabolism Gene Products, tat/isolation & purification,metabolism Genes, rev Genes, tat HIV Long Terminal Repeat HIV-1/genetics,metabolism HeLa Cells Humans Molecular Sequence Data Nucleic Acid Conformation Oligodeoxyribonucleotides Promoter Regions, Genetic RNA, Viral/genetics,metabolism Restriction Mapping Trans-Activators/genetics,metabolism Transcriptional Activation rev Gene Products, Human Immunodeficiency Virus tat Gene Products, Human Immunodeficiency Virus
Chemicals
Gene Products, rev Gene Products, tat Oligodeoxyribonucleotides RNA, Viral Trans-Activators rev Gene Products, Human Immunodeficiency Virus tat Gene Products, Human Immunodeficiency Virus Chloramphenicol O-Acetyltransferase
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Tiley L S
Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710.
Madore S J
Malim M H
Cullen B R
Article Info
Journal
Genes & development
Abbr.
Genes Dev
ISSN
0890-9369
Published
1992-11-00
Pages
2077-87
Language
English
Region
United States
NLM ID
8711660
Subset
IM
Grants
NIAID NIH HHS · AI28233 · United States
NIAID NIH HHS · AI28662 · United States
NIAID NIH HHS · AI29821 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]